460470.KQ IVIM Technology, Inc
- Market cap
- KRW 37.4B
- P/E
- -
- P/B
- 1.43x
- ROE
- -11.3%
- Dividend yield
- -
- Fundamental score
- 1.8/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 460470.KQ undervalued?
Graham numberThe Graham number of IVIM Technology, Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
IVIM Technology, Inc fundamental analysis
7 of 21 checks passedROE 0/2
Low return on equity (-11.3%), below 10%.
ROA 0/1
Return on assets (-10.3%) is below the industry median (-9.3%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (5.2%) is above the industry median (-3.8%).
Revenue Growth 2/2
Revenue grew 48.4% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (2.3%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Cash Runway 2/2
Cash covers 2.3 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (1.4x) is below the industry median (3.5x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
IVIM Technology, Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About IVIM Technology, Inc
IVIM Technology, Inc. develops intravital microscopy (IVM) platform. Its products include IVM-C3, a system for simultaneously observing various multi-cellular behaviors in small live animal models; IVM-M3, a system for users who need to conduct deeper-tissue imaging using less-scattering NIR wavelength; IVM-CMS3 for intravital functional imaging; IVM-CM3 that provides three-dimensional imaging of living cells near the skin or deep into the tumor in small animals; IVM-MS3 for…
Full company profileIVIM Technology, Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
IVIM Technology, Inc annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 527M | 1.34B | 4.50B | 3.56B | 4.38B | 6.11B |
| Gross Profit | -123M | 160M | 1.43B | 1.35B | 1.23B | 2.38B |
| Operating Income | -2.66B | -3.39B | -2.89B | -4.30B | -4.15B | -3.30B |
| EBITDA | - | -6.78B | -2.33B | -2.44B | -1.79B | -827M |
| Net Income | -2.62B | -9.74B | -5.04B | -4.00B | -3.80B | -2.95B |
| EPS | -207 | -651 | -337 | -265 | -252 | -195 |
| Balance Sheet | ||||||
| Total Assets | 6.95B | 19.1B | 16.5B | 34.9B | 30.2B | 28.7B |
| Total Liabilities | 17.4B | 39.2B | 3.71B | 3.61B | 2.59B | 2.55B |
| Shareholders' Equity | -10.4B | -20.0B | 12.8B | 31.3B | 27.6B | 26.2B |
| Cash & Short-term Investments | 1.36B | 12.0B | 8.06B | 22.5B | 3.21B | 4.60B |
| Cash Flow | ||||||
| Operating Cash Flow | -3.53B | -4.08B | -3.45B | -6.93B | -4.25B | -1.78B |
| Capital Expenditure | 1.39B | 422M | 496M | 664M | 2.48B | 185M |
| Free Cash Flow | -4.92B | -4.50B | -3.94B | -7.59B | -6.73B | -1.96B |
| Ratios | ||||||
| ROE | - | - | -39.3% | -12.8% | -13.8% | -11.3% |
| ROA | -37.7% | -50.8% | -30.5% | -11.5% | -12.6% | -10.3% |
| Net Profit Margin | -497.3% | -727.7% | -112.2% | -112.3% | -86.9% | -48.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
IVIM Technology, Inc dividends
IVIM Technology, Inc has not paid dividends in the last 5 fiscal years.
Who owns IVIM Technology, Inc
- Insiders 31.28%
- Institutions 8.33%
- Public & others 60.39%
- Shares outstanding 15.1M
- Free float 9.60M
IVIM Technology, Inc company profile
- Company name
- IVIM Technology, Inc
- Ticker
- 460470.KQ
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- December
- Address
- #B-415, Daedeok BizCenter 17, Daejeon, South Korea, 34013
- Phone
- 82 4 2825 7450
- Website
- ivimtech.com
About IVIM Technology, Inc
IVIM Technology, Inc. develops intravital microscopy (IVM) platform. Its products include IVM-C3, a system for simultaneously observing various multi-cellular behaviors in small live animal models; IVM-M3, a system for users who need to conduct deeper-tissue imaging using less-scattering NIR wavelength; IVM-CMS3 for intravital functional imaging; IVM-CM3 that provides three-dimensional imaging of living cells near the skin or deep into the tumor in small animals; IVM-MS3 for in vivo imaging; and IVM-customized products. The company also provides preclinical contract research organization services. Its products are used in live cell intravital imaging, repetitive intravital imaging, in vivo drug efficacy monitoring, in vivo drug delivery monitoring, and ex vivo imaging applications. The company was founded in 2017 and is based in Daejeon, South Korea.
IVIM Technology, Inc management
1- Dr. Pilhan KimChief Executive Officer · born 1978